Latest Administration News

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.

Cassius Mining Limited has successfully raised $1 million through a share placement to fund its Soalara project in Madagascar and ongoing litigation in Ghana, signaling a strategic push in key operational areas.

True North Copper Limited (ASX: TNC) has been reinstated to trading following the appointment of voluntary administrators, signaling a critical juncture for the copper miner’s future.

True North Copper has successfully completed a $53.44 million capital raising and debt restructuring, exiting voluntary administration and securing ASX reinstatement. The company shifts focus to exploration at Mt Oxide and Cloncurry, retracting prior production plans for the next 12 months.

Pacific Edge faces a significant Medicare reimbursement setback as Novitas finalizes a non-coverage decision for its Cxbladder tests, prompting the company to activate legal challenges and operational restructuring.

EBR Systems has announced a rescheduling of the FDA Pre-Approval Inspection for its wireless cardiac pacing device to January 14, 2025, while maintaining its regulatory approval timeline for Q1 2025 and a commercial launch later in the year.

EBR Systems Inc. has responded to ASX's price query, denying any undisclosed information behind recent trading spikes and confirming compliance with listing rules. The company also flagged an upcoming FDA inspection announcement.

JPMorgan Asset Management has announced estimated cash distributions for January 2025 across its suite of equity premium income ETFs, providing investors with key dates and payout expectations.